Our analysis of circulating levels of IL-1 family cytokines and receptors in AD patients demonstrates significant increases of almost all the anti-inflammatory effectors, in parallel to a small increase in the inflammatory cytokines IL-1α and IL-1β. The gene discussed is IL1A; the disease is Alzheimer disease.